Potential offtaker

Johnson & Johnson

www.jnj.com

N/A
N/A
Which other companies from United States of America are actively involved in decarbonization initiatives?
  • US General Services Administration
  • Mile Hi Bakery Inc.
  • Patagonia, Inc.
  • FPA Multifamily LLC
  • Lightsource BP
  • Sonoco Products Company
  • Johnson & Johnson is a multinational corporation that operates in the Large Pharma sector. The company is headquartered in New Brunswick, New Jersey, and has operations in over 60 countries worldwide. Johnson & Johnson is committed to sustainability and has taken several measures to reduce its carbon footprint and promote renewable energy.

    Decarbonisation is a key focus area for Johnson & Johnson. The company has set ambitious targets to reduce its greenhouse gas emissions and has made significant progress towards achieving them. In 2019, Johnson & Johnson announced its commitment to achieve carbon neutrality by 2030. The company plans to achieve this by reducing its operational emissions, investing in renewable energy, and offsetting any remaining emissions.

    Corporate energy is another area of focus for Johnson & Johnson. The company has implemented several initiatives to reduce its energy consumption and promote energy efficiency. For example, the company has invested in energy-efficient lighting and HVAC systems, and has implemented energy management systems to monitor and optimize energy use in its facilities. Johnson & Johnson has also implemented a global energy management program that includes energy audits, benchmarking, and energy performance tracking.

    Corporate power purchase agreements (PPAs) are another important part of Johnson & Johnson's sustainability strategy. PPAs allow the company to purchase renewable energy directly from renewable energy projects, such as wind and solar farms. By entering into PPAs, Johnson & Johnson is able to reduce its carbon footprint and support the development of renewable energy projects. In 2018, Johnson & Johnson signed a 12-year PPA for 100 MW of wind power in Texas, which is expected to generate enough electricity to power over 38,000 homes annually.

    Renewable energy is a key focus area for Johnson & Johnson. The company has set a target to source 35% of its electricity from renewable sources by 2020, and has already exceeded this target. In 2019, Johnson & Johnson announced its commitment to source 100% of its electricity from renewable sources by 2025. The company plans to achieve this by investing in renewable energy projects, entering into PPAs, and purchasing renewable energy certificates.

    Johnson & Johnson has also taken several other measures to promote sustainability and reduce its environmental impact. The company has implemented a global waste management program that includes waste reduction, recycling, and composting. Johnson & Johnson has also implemented a sustainable packaging program that includes the use of recycled materials and the reduction of packaging waste. In addition, the company has implemented a water stewardship program that includes water conservation, water reuse, and water quality monitoring.

    Overall, Johnson & Johnson is a leader in sustainability and has taken several measures to reduce its environmental impact. The company's focus on decarbonisation, corporate energy, corporate PPAs, and renewable energy is helping to drive the transition to a more sustainable future. Johnson & Johnson's commitment to sustainability is not only good for the environment, but also for its business, as it helps to reduce costs, improve efficiency, and enhance its reputation as a responsible corporate citizen.

    ✓ Current offtaker under Corporate PPA's
    ✓ Re100 Gold member
    ✓ Science Based Targets member
    ✓ Declared Net Zero commitment
    Decarbonization Pathways for Manufacture of basic pharmaceutical products: An Analysis

    Which companies in the industry of Manufacture of basic pharmaceutical products have made significant pledges or efforts to address global warming?
  • Ypsomed AG
  • Sanofi
  • AbbVie
  • Taiho Pharmaceutical Co. Ltd.
  • Otsuka Holdings